Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
ApexPrep DNA Plasmid Miniprep Kit for AML
2026-08-27
The ApexPrep DNA Plasmid Miniprep Kit uses alkaline lysis and membrane-based purification to produce molecular biology grade plasmid DNA from bacterial cultures. Its stated capacity is up to 30 μg from 1–5 mL per preparation, supporting cloning, sequencing, and functional AML research workflows.
-
Forskolin in HepaRG Assays: State Before Signal
2026-08-27
Forskolin is an adenylate cyclase activator whose value depends on both cAMP biology and cellular state. This article connects Forskolin assay design with accelerated HepaRG differentiation, showing how to separate pathway effects from model-maturation effects in translational research.
-
Canagliflozin and Renal Mitochondrial Phenotypes
2026-08-26
Canagliflozin is an SGLT2 inhibitor for investigating renal glucose handling and mitochondrial phenotypes. This article explains how to distinguish glucose-lowering effects from proximal-tubule remodeling and design more informative type 2 diabetes mellitus research assays.
-
HyperScribe T7 High Yield Cy5 RNA Labeling Kit
2026-08-26
Build bright, customizable RNA probes for in situ hybridization and Northern blot hybridization with a tunable Cy5-UTP workflow. The kit combines T7-driven transcription, random fluorescent nucleotide incorporation, and a 25-reaction format for flexible assay development.
-
TCF25, Lysosomal Acidification, and Glucose Starvation
2026-08-25
Ren et al. identify TCF25 as a nutrient-stress regulator that links glucose starvation to V-ATPase-dependent lysosomal acidification, autophagy, ferritinophagy, and lysosome-dependent cell death. The study provides a mechanistic framework for understanding how lysosomes shift from energy-supporting organelles to drivers of injury during prolonged metabolic stress.
-
KNUCKLES Controls Floral Meristem Termination
2026-08-25
This Arabidopsis study identifies KNUCKLES (KNU) as a chromatin-linked coordinator of auxin distribution and cytokinin activity during floral meristem termination. By repressing PIN1 and IPT7 through H3K27me3 deposition, KNU connects hormone regulation with the WUS–CLV3 stem-cell circuit and provides a stage-resolved explanation for floral determinacy.
-
Tacalcitol Monohydrate: VDR, NGF, and 5-FU
2026-08-24
Tacalcitol monohydrate is a synthetic analog of vitamin D3 that activates VDR-linked transcriptional programs in dermatology and cell-based oncology research. Its reported NGF induction, psoriasis relevance, and enhancement of 5-fluorouracil activity are assay-dependent findings rather than universal clinical effects.
-
PCN, Hippocampal CYPs, and Phenytoin Neurotoxicity
2026-08-24
Nkosi and Maseko report that pregnenolone 16α-carbonitrile suppresses hippocampal CYP expression and reduces phenytoin-associated neuronal injury through glucocorticoid receptor signaling rather than the expected PXR pathway. The work highlights tissue-specific nuclear-receptor pharmacology and provides a framework for studying neurosteroid metabolism in drug-induced neurotoxicity.
-
Lactate-GPR81 Control of Insulin-Independent Glucose Uptake
2026-08-23
The 2026 Cell Research study identifies L-lactate as an insulin-independent regulator of skeletal-muscle glucose uptake and defines a GPR81-FARP1-RAC1-GLUT4 signaling axis. Its genetic, pharmacological, exercise, and human genetic evidence suggests that lactate signaling may complement insulin-based glucose control, while also highlighting important questions about receptor specificity and translational scope.
-
Deferasirox Pharmacokinetics and Clinical Evidence
2026-08-22
Galanello, Campus, and Origa integrate pharmacokinetic, pharmacodynamic, efficacy, and safety evidence for oral deferasirox across transfusion-dependent anemias. The review’s main contribution is a clinically grounded framework linking iron burden, exposure, monitoring, adherence, and treatment response rather than treating chelation as a single-endpoint intervention.
-
Reporter mRNA as a Translational Stress Test
2026-08-22
Firefly Luciferase mRNA can do more than confirm transfection. With ARCA capping, 5mCTP, pseudouridine, and a defined poly(A) tail, it provides a mechanistically informative readout of delivery, cytosolic access, translation, and cell state. This article explains how to deploy the reporter strategically while interpreting its signal alongside emerging evidence on LNP immunogenicity and repeat-dose mRNA design.
-
Human iPSC Intestinal Organoids for Pharmacokinetics
2026-08-21
Saito and colleagues established a direct three-dimensional cluster-culture strategy for generating expandable intestinal organoids from human induced pluripotent stem cells. The resulting organoids can be cryopreserved, differentiated into intestinal epithelial monolayers, and evaluated for enterocyte CYP and transporter functions relevant to oral drug absorption and metabolism.
-
Vernakalant for Rapid Atrial Fibrillation Conversion
2026-08-20
This phase 3 randomized trial evaluated intravenous vernakalant as a rapid pharmacological strategy for converting atrial fibrillation to sinus rhythm. Vernakalant produced substantially faster and more frequent conversion than placebo in short-duration atrial fibrillation, while the study also highlighted the importance of monitored administration and safety assessment.
-
Lovastatin: From Mevalonate to Cell Phenotype
2026-08-20
Lovastatin is an HMG-CoA reductase inhibitor whose effects extend from cholesterol biosynthesis to proliferation, apoptosis, wound remodeling, and macrophage behavior. This article presents an assay-centered framework that connects product-specific evidence with the stage-resolved regulatory logic revealed in floral meristem research.
-
In Vitro Drug Response Metrics in Cancer
2026-08-19
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell killing are related but non-equivalent features of anticancer drug response. This framework supports better assay design by encouraging researchers to measure response magnitude, death, and timing as separate experimental variables.